Back
Atmos Energy Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
68
ATO
Atmos Energy
Last Price:
151.30
Seasonality Move:
0.9%
Buy
58
SRPT
Sarepta Therapeutics
Last Price:
133.49
Seasonality Move:
14.88%
Buy
68
Atmos Energy (ATO)
is a Buy
Is Atmos Energy a Buy, Sell or Hold?
- The current Atmos Energy [ATO] share price is $151.32. The Score for ATO is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- ATO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $133.34. The Score for SRPT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ATO Stock Price Chart
What is Atmos Energy's stock price today?
-
The Atmos Energy share price today is $151.32
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATO is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $133.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
ATO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.88 | Buy |
Relative Strength Index (14 RSI): | 74.12 | Buy |
Chaikin Money Flow: | 34073 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (139.95 - 149.07) | Buy |
Bollinger Bands (100): | (127.3 - 143.34) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.78 | Buy |
Relative Strength Index (14 RSI): | 63.54 | Buy |
Chaikin Money Flow: | -725343 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (110.85 - 129.81) | Buy |
Bollinger Bands (100): | (119.21 - 141.67) | Buy |
ATO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 149.7 | Buy |
20-day SMA: | 145.59 | Buy |
50-day SMA: | 141.95 | Buy |
200-day SMA: | 125.64 | Buy |
8-day EMA: | 149.66 | Buy |
20-day EMA: | 146.75 | Buy |
50-day EMA: | 142.12 | Buy |
200-day EMA: | 129.32 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 119.83 | Buy |
20-day SMA: | 118.14 | Buy |
50-day SMA: | 122.33 | Buy |
200-day SMA: | 130.09 | Buy |
8-day EMA: | 123.82 | Buy |
20-day EMA: | 120.48 | Buy |
50-day EMA: | 122.96 | Buy |
200-day EMA: | 126.17 | Buy |
Atmos Energy Earnings Growth & ATO Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $0.35 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.
Atmos Energy Technical Analysis
Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |